Official Publications Amgen Inc.

Equities

AMGN

US0311621009

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
312.5 ^USD	-0.71%		+0.75%	+8.49%

May. 17	US FDA approves Amgen drug for small cell lung cancer	RE
May. 17	FDA Approves Amgen's IMDELLTRA?? (Tarlatamab-Llle) for the Treatment of Adult Patients with Extensive-Stage Small Cell Lung Cancer	CI

Official Publications

SEC Filing 4K	23-03-16	CO
SEC Filing 4K	23-03-16	CO
SEC Filing 4K	23-03-16	CO
SEC Filing 4K	23-03-16	CO
SEC Filing 4K	23-03-16	CO
SEC Filing 4K	23-03-16	CO
SEC Filing 4K	23-03-16	CO
Dividends	23-03-06	CO
SEC Filing 8K	23-02-15	CO
SEC Filing 13G	23-02-09	CO
SEC Filing S3	23-02-08	CO
SEC Filing 13G	23-02-08	CO
SEC Filing 10K	23-02-08	CO
SEC Filing 13G	23-02-06	CO
SEC Filing 13G	23-02-05	CO
Slide show results	23-01-30	CO
Annual results	23-01-30	CO
SEC Filing 8K	23-01-30	CO
SEC Filing 8K	22-12-21	CO
SEC Filing 8K	22-12-11	CO
SEC Filing 13G	22-12-01	CO
SEC Filing 8K	22-12-01	CO
SEC Filing 10Q-3	22-11-03	CO
Slide show Q3	22-11-02	CO
3rd quarter results	22-11-02	CO

1 2 3 4

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW